Aclarubicin Hydrochloride

盐酸阿柔比星

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameAclarubicin Hydrochloride
Drug Alias Name阿克拉霉素Aaclarubicinum阿克拉霉素aclarubicineaclarubicina +[10] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTopoisomerase II inhibitorsDNA topoisomerase I inhibitors
TargetsTopoisomerase IIDNA topoisomerase I
Therapy Area/IndicationsLymphomaLeukemia
Global Approved IndicationsLymphomaLeukemia
Approved Indications in ChinaLymphomaLeukemia
Original Approved Country/TerritoryMainland China
Original Approved Date1992/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesSichuan Haikang Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsLymphomaLeukemia
Inactive IndicationsN/A

Other Information

ATC CodeL01DB04
Related LinksWikipediaDrugBankKEGG